Traders assign a 94.5% implied probability that Robert F. Kennedy Jr. remains HHS Secretary through October 31, reflecting sustained alignment with White House priorities on MAHA initiatives, vaccine policy revisions, and agency reorganization. Recent actions include signing determinations to phase out remaining COVID-19 emergency use authorizations, advancing supplemental funding awards, and preparing to address the Children’s Health Defense conference. Senate confirmation proceedings for his deputy nominee and continued implementation of department changes further signal stability. Although Democratic lawmakers and some healthcare organizations have issued reports and calls for resignation citing policy disputes, no official statements, procedural steps, or White House signals indicate an impending departure before the resolution window closes.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · AggiornatoSì
Sì
An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Mercato aperto: Sep 3, 2026, 9:28 AM ET
Risolutore
0x65070BE91...An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Risolutore
0x65070BE91...Traders assign a 94.5% implied probability that Robert F. Kennedy Jr. remains HHS Secretary through October 31, reflecting sustained alignment with White House priorities on MAHA initiatives, vaccine policy revisions, and agency reorganization. Recent actions include signing determinations to phase out remaining COVID-19 emergency use authorizations, advancing supplemental funding awards, and preparing to address the Children’s Health Defense conference. Senate confirmation proceedings for his deputy nominee and continued implementation of department changes further signal stability. Although Democratic lawmakers and some healthcare organizations have issued reports and calls for resignation citing policy disputes, no official statements, procedural steps, or White House signals indicate an impending departure before the resolution window closes.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · Aggiornato

Fai attenzione ai link esterni.
Fai attenzione ai link esterni.
Domande frequenti